15-Deoxy-Δ12, 14-prostaglandin J2 up-regulates the expression of 15-hydroxyprostaglandin dehydrogenase through DNA methyltransferase 1 inactivation. (4th March 2019)
- Record Type:
- Journal Article
- Title:
- 15-Deoxy-Δ12, 14-prostaglandin J2 up-regulates the expression of 15-hydroxyprostaglandin dehydrogenase through DNA methyltransferase 1 inactivation. (4th March 2019)
- Main Title:
- 15-Deoxy-Δ12, 14-prostaglandin J2 up-regulates the expression of 15-hydroxyprostaglandin dehydrogenase through DNA methyltransferase 1 inactivation
- Authors:
- Jang, Hye-Ok
Lee, Ha-Na
Woo, Jeong-Hwa
Lee, Ja-Young
Kim, Areumnuri
Lee, Jin Kyung
Kim, Do-Hee
Surh, Young-Joon
Na, Hye-Kyung - Abstract:
- Abstract: 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is the key enzyme that catalyses the conversion of prostaglandin E2 to a keto metabolite. The expression of 15-PGDH is ubiquitously repressed in various human malignancies. However, the molecular mechanisms underlying down-regulation of 15-PGDH expression remain largely unknown. 15-Deoxy-△ 12, 14 -prostaglandin J2 (15d-PGJ2 ), an endogenous ligand of peroxisome proliferator-activated receptor γ, has been reported to have anti-inflammatory and anticarcinogenic activities. In the present study, we have found that 15d-PGJ2 induces expression and catalytic activity of 15-PGDH in human breast cancer (MDA-MB-231) cells. 15d-PGJ2 decreased the level of CpG methylation in the 15-PGDH promoter in MDA-MB-231 cells as determined by the bisulphite genome sequencing and methyl-specific PCR. 15d-PGJ2 inhibited the catalytic activity of methyltransferase 1 (DNMT1) but did not influence its expression. Biotinylated 15d-PGJ2 directly interacted with DNMT1 and reduced its catalytic activity. Chromatin-immunoprecipitation analysis revealed that 15d-PGJ2 significantly attenuated DNMT1 binding to the activator protein-1 transcription factor present in the 15-PGDH promoter region. A nonelectrophilic analogue 9, 10-dihydro-15d-PGJ2 failed to suppress the methylation of CpG islands present in 15-PGDH promoter and did not affect both DNMT1 activity and 15-PGDH expression. These findings suggest that the α, β-unsaturated carbonyl group presentAbstract: 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is the key enzyme that catalyses the conversion of prostaglandin E2 to a keto metabolite. The expression of 15-PGDH is ubiquitously repressed in various human malignancies. However, the molecular mechanisms underlying down-regulation of 15-PGDH expression remain largely unknown. 15-Deoxy-△ 12, 14 -prostaglandin J2 (15d-PGJ2 ), an endogenous ligand of peroxisome proliferator-activated receptor γ, has been reported to have anti-inflammatory and anticarcinogenic activities. In the present study, we have found that 15d-PGJ2 induces expression and catalytic activity of 15-PGDH in human breast cancer (MDA-MB-231) cells. 15d-PGJ2 decreased the level of CpG methylation in the 15-PGDH promoter in MDA-MB-231 cells as determined by the bisulphite genome sequencing and methyl-specific PCR. 15d-PGJ2 inhibited the catalytic activity of methyltransferase 1 (DNMT1) but did not influence its expression. Biotinylated 15d-PGJ2 directly interacted with DNMT1 and reduced its catalytic activity. Chromatin-immunoprecipitation analysis revealed that 15d-PGJ2 significantly attenuated DNMT1 binding to the activator protein-1 transcription factor present in the 15-PGDH promoter region. A nonelectrophilic analogue 9, 10-dihydro-15d-PGJ2 failed to suppress the methylation of CpG islands present in 15-PGDH promoter and did not affect both DNMT1 activity and 15-PGDH expression. These findings suggest that the α, β-unsaturated carbonyl group present in 15d-PGJ2 is essential for its inactivation on DNMT1 and expression of 15-PGDH. In conclusion, 15d-PGJ2 plays as a hypomethylating agent through direct interaction with DNMT1 and consequently suppresses DNMT1-mediated hypermethylation of 15-PGDH promoter, leading to up-regulation of 15-PGDH expression. … (more)
- Is Part Of:
- Free radical research. Volume 53:Number 3(2019)
- Journal:
- Free radical research
- Issue:
- Volume 53:Number 3(2019)
- Issue Display:
- Volume 53, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 53
- Issue:
- 3
- Issue Sort Value:
- 2019-0053-0003-0000
- Page Start:
- 335
- Page End:
- 347
- Publication Date:
- 2019-03-04
- Subjects:
- 15d-PGJ2 -- 15-PGDH -- breast cancer -- DNMT1 -- methylation
Free radicals (Chemistry) -- Periodicals
Antioxidants -- Periodicals
Vitamin C -- Periodicals
Vitamin E -- Periodicals
541.224 - Journal URLs:
- http://informahealthcare.com/journal/fra ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/10715762.2019.1576867 ↗
- Languages:
- English
- ISSNs:
- 1071-5762
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4033.326495
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10211.xml